← SynDRA
LM11A-31
SynDRA canonical compound SYN1969885 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | NGFR |
|---|
| Mechanism of action | neurotrophic agent |
|---|
All known targets
Mechanisms of action (all sources)
- neurotrophic agent
- NGFR MODULATOR
Cross-references
Synonyms
- N-[2-(Morpholin-4-yl)ethyl]-L-isoleucinamide
- (2S,3S)-2-amino-3-methyl-N-(2-morpholin-4-ylethyl)pentanamide
- SCHEMBL1723692
- DTXSID50595097
- ZINC4239960
- (2S,3S)-2-amino-3-methyl-N-(2-morpholinoethyl)-pentanamide
- (2S,3S)-2-Amino-3-methyl-N-(2-morpholinoethyl)pentanamide
- RefChem:153852
- LM-11A-31
- Y9GUF3B7Q7
- GTPL13391
- YNMUTYLWSRFTPX-QWRGUYRKSA-N
- MFCD13245016
- BS-51733
- CS-0063684
- F74058
- F864984
- 4Y3A5U8Geg
- LM11A-31-BHS
- LM-11A-31-BHS
- SCHEMBL1815849
- AC9823
- LM11A-31 D8 dihydrochloride
- LM11A-31 2HCl
- GLXC-03348
- F836380
- LM11A-31 HCl
- LM-11A-31 dihydrochloride
- SY254127
- MFCD28166485
- T11861
- AKOS025142042
- orb1309474
- CS-0033016
- EX-A4496
- SCHEMBL19064539
- HY-110155
- LM11A-31 (dihydrochloride)
- AS-16801
Look up LM11A-31 in the interactive SynDRA portal →